Dr. O’Malley on the gender disparities among NCCN-cited trials for urothelial carcinoma
“These findings are an internal validation that the disparities we're seeing are real,” says Padraic O’Malley, MD, MSc, FRCSC.
In this video, Padraic O’Malley, MD, MSc, FRCSC, discusses the background and findings of the study, “Gender disparities in the clinical trials and real-world utilization of systemic therapy in the management of urothelial carcinoma,” which was presented recently at the Society of Women in Urology Annual Clinical Mentoring Conference. O’Malley is an assistant professor in the department of urology at the University of Florida in Gainesville.
Advancing bladder cancer care: The importance of integrating mental health support
September 9th 2024"I think the fact that we're having these conversations, that they are being talked about at national meetings, and that we are bringing the patient voice into this is hugely important," says Mary W. Dunn, MSN, NP-C, OCN, RN.
Speaking of Urology Podcast: Dr. Ritch and Dr. Katz discuss new bladder cancer management app
December 7th 2021“It's not a replacement for clinical judgment, obviously. But at the end of the day, the idea is that it shows you what your next steps are based on what the American Urological Association and [Society of Urologic Oncology] guidelines are for non-muscle invasive bladder cancer,” Chad R. Ritch, MD, MBA, FACS.
